Jacqui M. Hall
Senior Counsel
Overview
Jacqui Hall’s 20+ years of experience supporting biopharmaceutical and technology industries, including as in-house counsel, enables her to provide strategic and pragmatic counsel on a range of transactional matters.
Jacqui helps clients with complex manufacturing and supply chain agreements, license and research agreements with academic counterparties, and software and other technology-related agreements.
Career & Education
- Contracts Manager, Novartis Pharmaceuticals Corporation
- Handled a broad range of transactions, including licensing of biotechnology and software technologies
- Helped develop internal guidance on negotiating clinical trial agreements
- In-house Counsel, Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)
- Handled a broad range of transactions, including licensing of biotechnology and software technologies
- Drafted a variety of consulting, service, and manufacturing agreements
- Contracts Manager, Novartis Pharmaceuticals Corporation
- Suffolk University Law School, J.D., cum laude
- College of the Holy Cross, B.A.
- Massachusetts
- New York
- New Jersey
Representative Matters
- Counseled ex-U.S. portfolio company on its services agreement with ex-U.S. CDMO for IND-enabling development and GMP manufacture of drug substance and associated cell line license agreement, including royalty and milestone payment structure.
- Regularly advises clients ranging from early stage to those with marketed product on their services/supply agreements for development and manufacture of GMP material, including biologics.
- Drafted and negotiated multiple in-licenses of patent rights from top academic U.S. institution on behalf of major Boston-based venture capital backed portfolio companies.
- Represents clients on sponsored research agreements and MTAs with academic institutions in U.S. and ex-U.S. for research using client proprietary materials.
- Strategically counsels clients on agreements for client evaluation of proprietary industry materials and intellectual property.
- Represented UK-based client transitioning to a clinical stage company on a SaaS agreement for a data analytics platform.
